117 related articles for article (PubMed ID: 1316083)
1. Phagocytic activation of human neutrophils by the detergent component of fluosol.
Ingram DA; Forman MB; Murray JJ
Am J Pathol; 1992 May; 140(5):1081-7. PubMed ID: 1316083
[TBL] [Abstract][Full Text] [Related]
2. Role of perfluorochemical emulsions in the treatment of myocardial reperfusion injury.
Forman MB; Ingram DA; Murray JJ
Am Heart J; 1992 Nov; 124(5):1347-57. PubMed ID: 1442506
[TBL] [Abstract][Full Text] [Related]
3. Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical.
Babbitt DG; Forman MB; Jones R; Bajaj AK; Hoover RL
Am J Pathol; 1990 Feb; 136(2):451-9. PubMed ID: 2407126
[TBL] [Abstract][Full Text] [Related]
4. Activation of complement by Fluosol attributable to the pluronic detergent micelle structure.
Ingram DA; Forman MB; Murray JJ
J Cardiovasc Pharmacol; 1993 Sep; 22(3):456-61. PubMed ID: 7504138
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
[TBL] [Abstract][Full Text] [Related]
6. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation.
Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB
Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160
[TBL] [Abstract][Full Text] [Related]
7. Effect of perfluorochemical blood substitutes on human neutrophil function.
Virmani R; Fink LM; Gunter K; English D
Transfusion; 1984; 24(4):343-7. PubMed ID: 6087518
[TBL] [Abstract][Full Text] [Related]
8. Increased infection mortality and decreased neutrophil migration due to a component of an artificial blood substitute.
Lane TA; Lamkin GE
Blood; 1986 Aug; 68(2):351-4. PubMed ID: 3524707
[TBL] [Abstract][Full Text] [Related]
9. Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leukocytes.
Kolodgie FD; Farb A; Carlson GC; Wilson PS; Virmani R
J Am Coll Cardiol; 1994 Oct; 24(4):1098-108. PubMed ID: 7930204
[TBL] [Abstract][Full Text] [Related]
10. Effect of fluorocarbon blood substitute on neutrophil phagocytic function.
Xiao N; Lu XC; Chen HS; Yang ZH; Tian KL
Zhongguo Yao Li Xue Bao; 1989 Nov; 10(6):537-9. PubMed ID: 2561936
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phospholipase A2 activity by Fluosol, an artificial blood substitute.
Shakir KM; Williams TJ
Prostaglandins; 1982 Jun; 23(6):919-27. PubMed ID: 7122911
[TBL] [Abstract][Full Text] [Related]
12. Perfluorocarbon emulsion prevents eicoasanoid release in skeletal muscle ischemia and reperfusion.
Gennaro M; Mohan C; Ascer E
Cardiovasc Surg; 1996 Jun; 4(3):399-404. PubMed ID: 8782946
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms and therapy of myocardial reperfusion injury.
Forman MB; Virmani R; Puett DW
Circulation; 1990 Mar; 81(3 Suppl):IV69-78. PubMed ID: 2407376
[TBL] [Abstract][Full Text] [Related]
14. Perfluorochemical blood substitutes differentially alter human monocyte procoagulant generation and oxidative metabolism.
Janco RL; Virmani R; Morris PJ; Gunter K
Transfusion; 1985; 25(6):578-82. PubMed ID: 4071604
[TBL] [Abstract][Full Text] [Related]
15. Biochemical, metabolic and morphological characteristics of human neutrophil activation with pepstatin A.
Smith RJ; Bowman BJ; Iden SS; Kolaja GJ; Wiser SK
Immunology; 1983 Jun; 49(2):367-77. PubMed ID: 6303951
[TBL] [Abstract][Full Text] [Related]
16. Effects of a novel perfluorocarbon emulsion on neutrophil chemiluminescence in human whole blood in vitro.
Edwards CM; Lowe KC; Röhlke W; Geister U; Reuter P; Meinert H
Artif Cells Blood Substit Immobil Biotechnol; 1997 May; 25(3):255-60. PubMed ID: 9167840
[TBL] [Abstract][Full Text] [Related]
17. Modifications in the phagocytosis of human neutrophils induced by vinblastine and cytochalasin B: the effects of lithium.
Carulli G; Marini A; Azzarà A; Petrini M; Ruocco L; Ambrogi F
Acta Haematol; 1985; 74(2):81-5. PubMed ID: 3937420
[TBL] [Abstract][Full Text] [Related]
18. Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
Ward PA; Sulavik MC; Johnson KJ
Am J Pathol; 1984 Aug; 116(2):223-33. PubMed ID: 6087668
[TBL] [Abstract][Full Text] [Related]
19. Fluosol in myocardial reperfusion injury.
Murray JJ; Vitola JV; Schaer GL; Forman MB
J Am Coll Cardiol; 1995 Jun; 25(7):1742-3. PubMed ID: 7759734
[No Abstract] [Full Text] [Related]
20. Inhibition of neutrophil and monocyte defensive functions by nicotine.
Pabst MJ; Pabst KM; Collier JA; Coleman TC; Lemons-Prince ML; Godat MS; Waring MB; Babu JP
J Periodontol; 1995 Dec; 66(12):1047-55. PubMed ID: 8683417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
